Tauseef Butt

Tauseef Butt

Tauseef Butt

President & CEO


Tauseef Butt obtained his BS/MS from University of Dundee, Dundee, Scotland. He has a PhD in Mol Biology from the University of Glasgow, Glasgow Scotland. UK, He was a Staff Fellow at the National Institutes of Health, Bethesda, MD, before joining SmithKline (now GSK) Pharmaceuticals.

His group was responsible for several therapeutic areas during his 14 years in the SmithKline organization, where he led one of the first ubiquitin drug discovery efforts in the industry. Tauseef Butt was an Adjunct Professor of Biochemistry and Biophysics at the University of Pennsylvania, Philadelphia, from 1989-to 2000. He is an Adjunct Professor in Biomedical Engineering at Drexel University, Philadelphia PA. He is active in a number of national and regional biotechnology organizations.

Tauseef But is a co- founder of Progenra, Inc. He has raised over $100 million in capital over the last few years. Progenra Inc is dedicated to the discovery and development of innovative medicines by exploiting the ubiquitin-proteasome systems and PROTAC drugs. Currently, he is the CEO of Progenra. Dr Butt is also the co-founder of Abzyme Inc. a biotech company exploiting novel molecular evolutionary platforms to generate novel therapeutic antibodies.

back to top

Call For Abstracts

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.